ReviewCancer cell international2026
The paradigm-shifting roles of caspase-3 in cancer: from death towards resuscitation.
Review in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Valorization of Sardinian Grapevine Leaves as a Sustainable Source of Flavonols with Anticancer Potential.Antioxidants (Basel, Switzerland) · 2026Article
- Carvacrol induces apoptosis, modulates oxidative stress, and promotes G0/G1 cell cycle arrest in colorectal cancer cells.Molecular and cellular biochemistry · 2026Article
- Synthesis and Biological Evaluation of Thiophene-Bridged Indole-Artesunate Hybrids as Selective Anticancer Agents.ACS omega · 2026Article
- Therapeutic effects of cold plasma-activated water on MCF7 breast cancer tumors in a mouse model.BMC pharmacology & toxicology · 2026Article
- BlackenedMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In Taoism, all entities in the universe embody two complementary forces—Yin and Yang—that are oppositional yet unified. Their subtle interplay governs the direction and progression of events. Caspase-3 is renowned for mediating apoptosis, whereas accumulating evidence has revealed its role in stimulating compensatory proliferation. In cancer, while caspase-3 activation is traditionally regarded as tumor-suppressive due to its ability to induce cell death, particularly apoptosis, increasing evidence has highlighted its tumor-supportive functions. These dual roles of caspase-3 exemplify the Taoist principle of “Yin and Yang”. This review begins by outlining the canonical apoptotic role of caspase-3, and then discusses its non-apoptotic roles across diverse pathophysiological contexts, with specific emphasis on its tumor-supportive mechanisms in: tumor repopulation, tumor angiogenesis, tumorigenesis, tumor migration, invasion and metastasis, cancer stem cell maintenance, therapy resistance, and tumor immune response. The emerging tumor-promoting functions of caspase-3 challenge the conventional therapeutic paradigm of activating caspase-3. Instead, caspase-3 inhibition may represent a promising alternative strategy for cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.